Double mutant fibrillin-1 (FBN1) allele in a patient with neonatal Marfan syndrome.

It is now well established that defects in fibrillin-1 (FBN1) cause the variable and pleiotropic features of Marfan syndrome (MFS) and, at the most severe end of its clinical spectrum, neonatal Marfan syndrome (nMFS). Patients with nMFS have mitral and tricuspid valve involvement and aortic root dilatation, and die of congestive heart failure, often in the first year of life. Although mutations in classical MFS have been observed along the entire length of the FBN1 mRNA, mutations in nMFS appear to cluster in a relatively small region of FBN1, approximately between exons 24 and 34. Here we describe the appearance of two FBN1 mutations in a single allele of an infant with nMFS. The changes were within six bases of each other in exon 26. One was a T3212G transversion resulting in an I1071S amino acid substitution and the second was an A3219T transversion resulting in an E1073D amino acid substitution. This is the first reported double mutant allele in FBN1.

[1]  R E Pyeritz,et al.  Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. , 1995, American journal of human genetics.

[2]  L. Kalaydjieva,et al.  Double mutant alleles: are they rare? , 1995, Human molecular genetics.

[3]  U. Francke,et al.  A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection. , 1995, American journal of human genetics.

[4]  D. Milewicz,et al.  A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. , 1995, The Journal of clinical investigation.

[5]  C. Price,et al.  Recurrent mis-splicing of fibrillin exon 32 in two patients with neonatal Marfan syndrome. , 1995, Human molecular genetics.

[6]  L. Tsui,et al.  The cystic fibrosis transmembrane conductance regulator gene. , 1995, American journal of respiratory and critical care medicine.

[7]  L. Peltonen,et al.  A compound-heterozygous Marfan patient: two defective fibrillin alleles result in a lethal phenotype. , 1994, American journal of human genetics.

[8]  A. Chumakov,et al.  Mutant p53 proteins behave in a dominant, negative fashion in vivo. , 1994, Anticancer research.

[9]  H. Firth,et al.  Differential allelic expression of a fibrillin gene (FBN1) in patients with Marfan syndrome. , 1994, American journal of human genetics.

[10]  B. Sykes,et al.  A new missense mutation of fibrillin in a patient with Marfan syndrome. , 1994, Journal of medical genetics.

[11]  D. Milewicz,et al.  Severe neonatal Marfan syndrome resulting from a de novo 3-bp insertion into the fibrillin gene on chromosome 15. , 1994, American journal of human genetics.

[12]  C. Hayward,et al.  Two novel mutations and a neutral polymorphism in EGF-like domains of the fibrillin gene (FBN1): SSCP screening of exons 15-21 in Marfan syndrome patients. , 1994, Human molecular genetics.

[13]  L. Peltonen,et al.  A novel mutation of the fibrillin gene causing ectopia lentis. , 1994, Genomics.

[14]  U. Francke,et al.  Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndrome. , 1993, Human molecular genetics.

[15]  U. Francke,et al.  Mutation screening of complete fibrillin-1 coding sequence: report of five new mutations, including two in 8-cysteine domains. , 1993, Human molecular genetics.

[16]  L. Tsui,et al.  A mutation in CFTR produces different phenotypes depending on chromosomal background , 1993, Nature Genetics.

[17]  H. Dietz,et al.  Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. , 1993, Genomics.

[18]  W. L. Robertson,et al.  Prenatal diagnosis and a donor splice site mutation in fibrillin in a family with Marfan syndrome. , 1993, American journal of human genetics.

[19]  B. Sykes,et al.  A novel fibrillin mutation in the Marfan syndrome which could disrupt calcium binding of the epidermal growth factor-like module. , 1993, Human molecular genetics.

[20]  David Valle,et al.  The skipping of constitutive exons in vivo induced by nonsense mutations , 1993, Science.

[21]  L. Peltonen,et al.  Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Puffenberger,et al.  Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. , 1992, The Journal of clinical investigation.

[23]  Ada Hamosh,et al.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene , 1991, Nature.

[24]  F. Bieber,et al.  Diagnosis and management of infantile marfan syndrome. , 1990, Pediatrics.

[25]  B. Theophilus,et al.  Complex alleles of the acid beta-glucosidase gene in Gaucher disease. , 1990, American journal of human genetics.

[26]  T. Geva,et al.  Two-dimensional and Doppler echocardiographic and pathologic characteristics of the infantile Marfan syndrome. , 1990, The American journal of cardiology.

[27]  R. Pyeritz,et al.  The Marfan syndrome in early childhood: analysis of 15 patients diagnosed at less than 4 years of age. , 1983, The American journal of cardiology.

[28]  Z. Lababidi,et al.  Early cardiac manifestations of Marfan's syndrome in the newborn. , 1981, American heart journal.

[29]  A. Rosenthal,et al.  Cardiac Manifestations of Marfan Syndrome in Infancy and Childhood , 1973, Circulation.

[30]  R. Lauer,et al.  Lethal tricuspid and mitral regurgitation in Marfan's syndrome. , 1967, The American journal of cardiology.

[31]  B. Burton,et al.  Three novel fibrillin mutations in exons 25 and 27: Classic versus neonatal Marfan syndrome , 1997, Human mutation.

[32]  L. Peltonen,et al.  Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome , 1994, Nature Genetics.

[33]  P. Beighton,et al.  McKusick's heritable disorders of connective tissue , 1993 .

[34]  T. Dörk,et al.  A cystic fibrosis allele encoding missense mutations in both nucleotide binding folds of the cystic fibrosis transmembrane conductance regulator , 1992, Human mutation.

[35]  H. Dietz,et al.  Clustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF‐like domains , 1992, Human mutation.

[36]  H. Dietz,et al.  Fabrillin (FBN1) mutations in Marfan syndrome , 1992, Human mutation.